NUVL insider buying & filings

NUVLNuvalent, Inc.

NASDAQ · Healthcare · $9.79B

$123.96

+0.00% · Jul 21

250 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Jul 8 · scanned 7m ago

Price · 1Y · daily● 1 sell

▸ hover a marker for the filing · drag to zoom · 2 moves explained

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$9.79B

Float

49.1M

67% public

Short % float

Pro

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Jul 8SELLPorter James Richard10b5-1President and CEOdirect30,000 @ $123.72$3.71M

Jul 8EXERCISEPorter James Richard10b5-1President and CEOdirect30,000 @ $18.93$567.9K

Jun 18GRANTFlynn James E10% ownerindirect3,444 sh—

Jun 18GRANTWheeler CameronDirectordirect3,444 sh—

Jun 18GRANTSrivastava SapnaDirectordirect3,444 sh—

Context

Wall St

$128.13 avg target

+3.4% vs today · 16 analysts · consensus Hold

▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice

Earnings · EPS vs forecast

0 of 4 quarters beat

Q1 '26−$1.39 act−$0.08

Q4 '25−$1.58 act−$0.14

Q3 '25−$1.70 act−$0.38

Q2 '25−$1.39 act−$0.24

Coverage

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice